Evidence map›Paper›PMID 31508907›Full record

ArticleJournal of cachexia, sarcopenia and muscle2019

Differentially methylated gene patterns between age-matched sarcopenic and non-sarcopenic women.

Lingxiao He, Praval Khanal, Christopher I Morse, Alun Williams, Martine Thomis

Abstract read
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Epigenetics of Skeletal Muscle Atrophy.International journal of molecular sciences · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. [Numerical expression of the clinical course of the disease. Data management].Revista medica del Instituto Mexicano del Seguro Social · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Potential Roles of miRNA-1245a Regulatory Networks in Sarcopenia.International journal of general medicine · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lingxiao HeDepartment of Movement Sciences, Physical Activity, Sports & Health Research Group, KU Leuven, Leuven, Belgium.ORCID 0000-0002-2395-6035
Praval KhanalDepartment of Movement Sciences, Physical Activity, Sports & Health Research Group, KU Leuven, Leuven, Belgium.
Christopher I MorseDepartment of Sport and Exercise Sciences, Manchester Metropolitan University, Manchester, UK.
Alun WilliamsDepartment of Sport and Exercise Sciences, Manchester Metropolitan University, Manchester, UK.
Martine ThomisDepartment of Movement Sciences, Physical Activity, Sports & Health Research Group, KU Leuven, Leuven, Belgium.ORCID 0000-0001-9093-2191

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSarcopenia is characterized by progressive decreases in muscle mass, muscle strength, and muscle function with ageing. Although many studies have investigated the mechanisms of sarcopenia, its connection with epigenetic factors, such as DNA methylation, still remains poorly understood. The aim of this study was to explore sarcopenia-related DNA methylation differences in blood samples between age-matched sarcopenic and non-sarcopenic older women.

methodsA sarcopenic group (n = 24) was identified and selected from a set of 247 older Caucasian women (aged 65-80 years) based on cut-off points of skeletal muscle index at 6.75 kg/m

resultsThe global methylation level of all analysed CpG sites (n = 788 074) showed no significant difference between the sarcopenic and non-sarcopenic groups (0.812), while the average methylation level of dmCpGs (n = 6258) was significantly lower in the sarcopenic group (0.004). The sarcopenic group had significantly higher methylation levels in TSS200 (the region from transcription start site to 200 nucleotides upstream of the site) and lower methylation levels in gene body and 3'UTR regions. In respect of CpG regions, CpG islands in promoters and some intragenic regions showed greater levels of methylation in the sarcopenic group. dmCpG-related KEGG pathways were mainly associated with muscle function, actin cytoskeleton regulation, and energy metabolism. Seven genes (HSPB1, PBX4, CNKSR3, ORMDL3, MIR10A, ZNF619, and CRADD) were found with the same methylation direction as previous studies of blood sample methylation during ageing. Fifty-four genes were shared with previous studies of resistance training.

conclusionsOur results improve understanding of epigenetic mechanisms of sarcopenia by identifying sarcopenia-related DNA methylation differences in blood samples of older women. These methylation differences suggest underlying alterations of gene expression and pathway function, which can partially explain sarcopenia-related muscular changes.

Indexed as

DNA MethylationGene Regulatory NetworksAgedAged, 80 and overAgingCase-Control StudiesCpG IslandsEpigenesis, GeneticFemaleHumansOligonucleotide Array Sequence AnalysisSarcopeniaDifferentially methylated CpG sitesDNA methylationOlder womenPathway analysisSarcopenia

Identifiers

PMID31508907
PMCPMC6903450

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.